References
- Lindemans CA, van Besien K. Topping it up: methods to improve cord blood transplantation outcomes by increasing the number of CD34+ cells. Cytotherapy. 2015;17:723–729.
- Liu H, van Besien K. Alternative donor transplantation – “mixing and matching”: the role of combined cord blood and haplo-identical donor transplantation (haplo-cord SCT) as a treatment strategy for patients lacking standard donors? Curr Hematol Malig Rep. 2015;10:1–7.
- Kwon M, Bautista G, Balsalobre P, et al. Haplo-cord transplantation using CD34+ cells from a third-party donor to speed engraftment in high-risk patients with hematologic disorders. Biol Blood Marrow Transplant. 2014;20:2015–2022.
- Liu H, Rich ES, Godley L, et al. Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions. Blood. 2011;118:6438–6445.
- van Besien K, Hari P, Zhang MJ, et al. Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and survival free of progression and GVHD (GRFS). Haematologica. 2016;101:634–643.
- Tsai SB, Liu H, Shore T, et al. Frequency and risk factors associated with cord graft failure (CGF) after transplant with single unit umbilical cord cells supplemented by haploidentical cells (Haplo-Cord) with reduced-intensity conditioning. Biol Blood Marrow Transplant. 2016;22:1065–1072.
- Eapen M, Klein JP, Ruggeri A, et al. Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. Blood. 2014;123:133–140.
- Giralt S, Thall PF, Khouri I, et al. Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood. 2001;97:631–637.
- van Besien K, Koshy N, Gergis U, et al. Cord blood chimerism and relapse after haplo-cord transplantation. Leuk Lymphoma. 2016. [Epub ahead of print]. doi: 10.1080/10428194.2016.1190970.
- Eldjerou LK, Chaudhury S, Baisre-de Leon A, et al. An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment. Blood. 2010;116:3999–4006.
- Barker JN, Byam C, Scaradavou A. How I treat: the selection and acquisition of unrelated cord blood grafts. Blood. 2011;117:2332–2339.
- Yoshihara S, Taniguchi K, Ogawa H, et al. The role of HLA antibodies in allogeneic SCT: is the type-and-screen strategy necessary not only for blood type but also for HLA? Bone Marrow Transplant. 2012;47:1499–1506.
- Tian X, Wilder J, Gormley N, et al. NK cell KIR ligand mismatches influence engraftment following combined haploidentical and umbilical cord blood (UCB) transplantation in patients with severe aplastic anemia (SAA). Blood. 2013;122:2038–2038.
- Lindemans CA, Chiesa R, Amrolia PJ, et al. Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome. Blood. 2014;123:126–132.
- Lindemans CA, Te Boome LC, Admiraal R, et al. Sufficient immunosuppression with thymoglobulin is essential for a successful haplo-myeloid bridge in haploidentical-cord blood transplantation. Biol Blood Marrow Transplant. 2015;21:1839–1845.